The findings of our studies suggest that carriers of CCR5-Δ32 polymorphism are at higher risk of developing microvascular complications such as diabetic retinopathy [22] as well as concomitant autoimmune disorders — celiac disease and inflammatory thyroid disease [23]. Here, CCR5 is linked to autoimmune disease.